Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:419-425
Published online before print December 18, 2008, doi: 10.1161/STROKEAHA.108.527507
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/2/419    most recent
STROKEAHA.108.527507v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodés-Cabau, J.
Right arrow Articles by Bertrand, O. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodés-Cabau, J.
Right arrow Articles by Bertrand, O. F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Other arteriosclerosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Risk Factors for Stroke
Right arrow Stroke in Children and the Young

(Stroke. 2009;40:419.)
© 2009 American Heart Association, Inc.


Original Contributions

Atherosclerotic Burden Findings in Young Cryptogenic Stroke Patients With and Without a Patent Foramen Ovale

Josep Rodés-Cabau, MD, FESC; Martin Noël, PhD; Alier Marrero, MD; Donald Rivest, MD; Ariane Mackey, MD; Christine Houde, MD; Elizabeth Bédard, MD; Eric Larose, MD; Steve Verreault, MD; Marc Peticlerc, MD; Philippe Pibarot, PhD; Peter Bogaty, MD Olivier F. Bertrand, MD, PhD

From the Quebec Heart Institute (J.R.-C., M.N., E.B., E.L., P.P., P.B., O.F.B.), Laval Hospital, Québec, Canada; the Department of Neurology (A.M., A.M., S.V.), Hôpital de l’Enfant Jesus, Québec, Canada; the Department of Neurology (D.R., M.P.), Hôtel Dieu de Lévis, Lévis, Canada; and the Centre Hospitalier Universitaire Laval (C.H.), Québec, Canada.

Correspondence to Josep Rodés-Cabau, MD, FESC, Quebec Heart Institute, Laval Hospital, 2725, chemin Ste-Foy, G1V 4G5 Quebec, Canada. E-mail josep.rodes{at}crhl.ulaval.ca

Background and Purpose— To further determine the mechanisms of cryptogenic stroke or transient ischemic attack in young patients, we evaluated indices of atherosclerosis in patients ≤55 years old diagnosed with cryptogenic cerebrovascular event comparing those with patent foramen ovale (PFO) with those without PFO.

Methods— This was a prospective study including 100 consecutive patients ≤55 years old (mean age, 45±8 years; 56 males) diagnosed with cryptogenic stroke/transient ischemic attack. PFO was identified in 59 of these patients with the use of transesophageal echocardiography with contrast study. The following surrogate markers of atherosclerosis were evaluated in all patients: carotid intima media thickness as measured by carotid ultrasonography and endothelial function as determined by brachial flow-mediated vasodilation. The same measurements were obtained in a control group of 50 age- and sex-matched control subjects.

Results— Patients without PFO were more likely to be current smokers and obese and more frequently had a history of hypertension and dyslipidemia. Carotid intima media thickness measurements were higher (P<0.0001) in patients without PFO (1.03±0.31 mm) compared with those with PFO (0.75±0.20 mm) and control subjects (0.79±0.17 mm). The absence of PFO was also associated with lower brachial flow-mediated vasodilation (without PFO: 5.04±3.39%; with PFO: 7.16±4.09%; control subjects: 7.33±4.07%; P=0.02). There were no differences in carotid intima media thickness and flow-mediated vasodilation between patients with stroke/transient ischemic attack with PFO and control subjects. The presence of PFO was independently associated with reduced carotid intima media thickness (P<0.0001) and increased flow-mediated vasodilation (P=0.019).

Conclusions— In patients ≤55 years old diagnosed with cryptogenic stroke/transient ischemic attack, the presence of PFO was associated with a lower atherosclerotic burden as measured by carotid intima media thickness and endothelial function with no differences compared with a control group without cerebrovascular event. These results suggest that an atherosclerotic-mediated mechanism may be involved in cryptogenic stroke/transient ischemic attack in patients without PFO, whereas a nonatherosclerotic mechanism may mediate the cerebrovascular event in the presence of PFO.


Key Words: atherosclerosis • carotid arteries • patent foramen ovale • stroke